Overall rank by patents
#25,076
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 13 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B66C (CRANES; LOAD-ENGAGING ELEMENTS OR DEVICES FOR CRANES, CAPSTANS, WINCHES, OR TACKLES).
The verdict
Reel holds 11 US patents across 13 technology areas, rank #25,076 of 50,000 tracked assignees.
Reel, Inc. has been granted 11 US utility patents between 2016 and 2025, placing Reel, Inc. at rank #25,076 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in B66C (CRANES; LOAD-ENGAGING ELEMENTS OR DEVICES FOR CRANES, CAPSTANS, WINCHES, OR TACKLES). As a US Corporation, Reel, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Reel sits between Realeyes Oü (11 patents, rank #25,072) and Renew Medical Inc. (11 patents, rank #25,080) - the closest US assignees by grant volume. The composite Innovation Score of 52.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 4 in the 2015–2019 window, a +75% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Reel, Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Reel, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Realeyes OÜ
11 patents
Rectorseal, LLC
11 patents
Redberry Systems, Inc.
11 patents
Redfin Corporation
11 patents
Relationship Science LLC
11 patents
Remediation Products, Inc.
11 patents
Renault Trucks
11 patents
Renew Medical Inc.
11 patents
Reel, Inc.
11 patents
What this shows Reel holds 11 patents at rank #25,076, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Reel's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 18.2% |
| 2017 | 1 | 9.1% |
| 2019 | 1 | 9.1% |
| 2023 | 3 | 27.3% |
| 2024 | 2 | 18.2% |
| 2025 | 2 | 18.2% |
Top 13 of 13 technology areas
Overall rank by patents
#25,076
Across all tracked assignees
52.1 out of 100
How to use this portfolio
Reel's 11 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.